Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|April 12, 2008
Development and validation of dissolution test for lopinavir, a poorly water-soluble drug, in soft gel capsules, based on in vivo dataEliane Maria Donato, Laura Alegria Martins, Pedro Eduardo Fröehlich, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|February 27, 2019
Hepatitis C virus-induced glomerular disease and posterior reversible encephalopathy syndrome after liver transplant: Case report and literature reviewFabrizio Fabrizi, Aldo Paolucci, Barbara Antonelli, et al.
International Journal of Colorectal Disease|September 5, 2008
Aberrant crypt foci: endoscopic assessment and cell kinetics characterizationPedro Figueiredo, Maria Donato, Marta Urbano, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|March 5, 2020
Ribavirin as a beneficial treatment option for hepatitis C virusassociated glomerular diseaseFabrizio Fabrizi, Donata Cresseri, Gabriella Moroni, et al.
Clinical Transplantation|April 3, 2020
Efficacy and safety of device-assisted enteroscopy ERCP in liver transplantation: A systematic review and meta-analysisFrancesca Ferretti, Mirella Fraquelli, Paolo Cantù, et al.
Current Reviews in Clinical and Experimental Pharmacology|September 3, 2021
Direct-acting Antivirals Inducing HCV-RNA Sustained Suppression Improve Xerophthalmia in HCV-infected PatientsBenedetto Caroleo, Lidia Colangelo, Maria Donato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 9, 2021
Safe pregnancy after liver transplantation: Evidence from a multicenter Italian collaborative studySalvatore Stefano Sciarrone, Alberto Ferrarese, Debora Bizzaro, et al.
Haematologica|March 21, 2019
High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenanceJosé A García-Marco, Javier López Jiménez, Valle Recasens, et al.
Pageof 1